Conference Insider
04/25/2012
Chicago—A genetic substudy of a phase 3 trial found that the benefit of ticagrelor compared with clopidogrel in patients with acute coronary syndrome (ACS) was not based on the presence of poor metabolizers of clopidogrel in the overall...
Chicago—A genetic substudy of a phase 3 trial found that the benefit of ticagrelor compared with clopidogrel in patients with acute coronary syndrome (ACS) was not based on the presence of poor metabolizers of clopidogrel in the overall...
Chicago—A genetic substudy of a...
04/25/2012
First Report Managed Care